Baby Safety / Compounds / Dibutyl phthalate (DBP)

Is Dibutyl phthalate (DBP) safe for babies and kids?

Elevated risk for kids

Infants are highly exposed to Dibutyl phthalate (DBP) through mouthing of plastic toys, teethers, bottles, and food packaging leachates. Endocrine disruption risk is amplified during critical windows of reproductive and neurological development.

What is dibutyl phthalate (dbp)?

The IUPAC name is dibutyl benzene-1,2-dicarboxylate.

Also known as: dibutyl benzene-1,2-dicarboxylate, dibutyl phthalate, Di-n-butyl phthalate, n-Butyl phthalate.

IUPAC name
dibutyl benzene-1,2-dicarboxylate
CAS number
84-74-2
Molecular formula
C16H22O4
Molecular weight
278.34 g/mol
SMILES
CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC
PubChem CID
3026

Risk for babies

Elevated risk

Infants are highly exposed to Dibutyl phthalate (DBP) through mouthing of plastic toys, teethers, bottles, and food packaging leachates. Endocrine disruption risk is amplified during critical windows of reproductive and neurological development.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

High risk

Pregnant women and their fetuses are the population of greatest concern for DBP toxicity due to the compound's potent anti-androgenic effects during fetal development. DBP crosses the placenta freely; fetal testicular Leydig cells are exquisitely sensitive to DBP-mediated disruption of testosterone synthesis during the masculinization programming window. In male fetuses, DBP exposure during this window causes phthalate syndrome: reduced anogenital distance (AGD), cryptorchidism, hypospadias, and later reproductive impairment. Epidemiological studies (including Swan 2005, published in Environmental Health Perspectives) found significant inverse associations between prenatal urinary phthalate metabolite levels and AGD in male infants. DBP is classified as Reproductive Toxicant Category 1B under EU REACH and the GHS system. Pregnant women should minimize use of nail polish and other cosmetics containing DBP, avoid handling printed receipts extensively, and limit exposure to PVC products that may off-gas phthalates (new PVC flooring, car interiors).

Regulatory consensus

13 regulatory and scientific bodies have classified Dibutyl phthalate (DBP). The classifications differ — that's the data.

AgencyYearClassificationNotes
IARC2000Group 3 (not classifiable as to carcinogenicity)IARC Monograph 73 (2000). Insufficient evidence in humans and animals for carcinogenicity classification. However, DBP is a confirmed reproductive toxicant via anti-androgenic mechanism: inhibits testosterone synthesis in fetal Leydig cells during the masculinization programming window (MPW, GD15.5–18.5 in rodents), causing testicular dysgenesis syndrome (TDS) — cryptorchidism, hypospadias, reduced anogenital distance. REACH SVHC (Substance of Very High Concern) — reproductive toxicant Category 1B. EU Annex XIV authorization required for uses. DBP is grouped with DEHP and BBP as the 'anti-androgenic phthalate cluster' of highest concern.
EPA CTX / IRIS—D (Not classifiable as to human carcinogenicity)
EPA CTX / Health Canada—Group VI: CEPA (unclassifiable with respect to carcinogenicity to humans)
EPA CTX / EPA OPP—Group D Not Classifiable as to Human Carcinogenicity
EPA CTX / Genetox—Genotoxicity: negative (Ames: negative, 1 positive / 4 negative reports)
EPA CTX / Genetox—Genotoxicity: negative (Ames: negative, 1 positive / 4 negative reports)
EPA CTX / Skin-Eye—Skin Irritation: Not classified (score: low)
EPA CTX / Skin-Eye—Eye Irritation: Not classified (score: low)
EPA CTX / Skin-Eye—Skin Sensitization: Category 1 (score: high)
EPA CTX / Skin-Eye—Eye Irritation: Category 6.4A (Category 2A) (score: high)
EPA CTX / Skin-Eye—skin irritation: in vivo: Studies Indicate No Significant Irritation (score: low)
EPA CTX / Skin-Eye—eye irritation: in vivo: Studies Indicate No Significant Irritation (score: low)
EPA CTX / Skin-Eye—skin sensitisation: in vivo (non-LLNA): Not likely to be sensitizing (score: low)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter dibutyl phthalate (dbp)

  • Consumer Products — Plastic bottles and containers, Food packaging, Plastic toys and household items
  • Drinking Water — Leaching from plastic pipes, Migration from bottled water containers
  • Indoor Environments — Off-gassing from plastic furniture, Degradation of plastic products
  • Fragrance — perfume, cologne, scented personal care products, household fragrance products, candles
    Identified in Fragrance Ingredient Safety Priority Research database (2,325 ingredients)

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Dibutyl phthalate (DBP):

  • DINCH
    Trade-offs: Performance differences in some applications
    Relative cost: 1.2-2×
  • Fragrance-free formulations
    Trade-offs: Consumer preference for scented products
    Relative cost: Lower (ingredient elimination)
  • Essential oil-based fragrances (with disclosure)
    Trade-offs: Natural does not mean safe — many essential oils are skin sensitizers
    Relative cost: 2-5× conventional

Frequently asked questions

Is dibutyl phthalate (dbp) safe for kids?

Infants are highly exposed to Dibutyl phthalate (DBP) through mouthing of plastic toys, teethers, bottles, and food packaging leachates. Endocrine disruption risk is amplified during critical windows of reproductive and neurological development.

What products contain dibutyl phthalate (dbp)?

Dibutyl phthalate (DBP) appears in: Plastic bottles and containers (Consumer products); Food packaging (Consumer products); Leaching from plastic pipes (Drinking water); Migration from bottled water containers (Drinking water); Off-gassing from plastic furniture (Indoor environments).

What should I do if my child is exposed to dibutyl phthalate (dbp)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about dibutyl phthalate (dbp)?

Dibutyl phthalate (DBP) has been classified by 13 agencies including IARC, EPA CTX / IRIS, EPA CTX / Health Canada, EPA CTX / EPA OPP, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Dibutyl phthalate (DBP) in the baby app

Look up products containing dibutyl phthalate (dbp), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)
  1. IARC Monographs Volume 73: Dibutyl Phthalate — Evaluation of Carcinogenic Risks to Humans (Group 3) (2000) — regulatory
  2. US EPA: Dibutyl Phthalate — IRIS Toxicological Review and Reference Doses (2006) — regulatory
  3. ECHA/EU REACH: Dibutyl Phthalate — Substance of Very High Concern (SVHC) Identification, Reproductive Toxicant Category 1B, Annex XIV Restriction (2011) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →